BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 7521890)

  • 1. Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines.
    Weller M; Frei K; Groscurth P; Krammer PH; Yonekawa Y; Fontana A
    J Clin Invest; 1994 Sep; 94(3):954-64. PubMed ID: 7521890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protooncogene bcl-2 gene transfer abrogates Fas/APO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiation.
    Weller M; Malipiero U; Aguzzi A; Reed JC; Fontana A
    J Clin Invest; 1995 Jun; 95(6):2633-43. PubMed ID: 7539458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fas/APO-1 gene transfer for human malignant glioma.
    Weller M; Malipiero U; Rensing-Ehl A; Barr PJ; Fontana A
    Cancer Res; 1995 Jul; 55(13):2936-44. PubMed ID: 7540953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous expression of transforming growth factor beta1 inhibits growth and tumorigenicity and enhances Fas-mediated apoptosis in a murine high-grade glioma model.
    Ashley DM; Kong FM; Bigner DD; Hale LP
    Cancer Res; 1998 Jan; 58(2):302-9. PubMed ID: 9443409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand.
    Mitsiades N; Poulaki V; Tseleni-Balafouta S; Koutras DA; Stamenkovic I
    Cancer Res; 2000 Aug; 60(15):4122-9. PubMed ID: 10945619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of death (CD95/FAS), activation and adhesion (CD54) molecules on blast cells of acute myelogenous leukemias by TNF-alpha and IFN-gamma.
    Munker R; Andreeff M
    Cytokines Mol Ther; 1996 Sep; 2(3):147-59. PubMed ID: 9384699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD95 (Fas/APO-1) antibody-mediated apoptosis of human retinal pigment epithelial cells.
    Esser P; Heimann K; Abts H; Fontana A; Weller M
    Biochem Biophys Res Commun; 1995 Aug; 213(3):1026-34. PubMed ID: 7544578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overcoming tumor necrosis factor and drug resistance of human tumor cell lines by combination treatment with anti-Fas antibody and drugs or toxins.
    Morimoto H; Yonehara S; Bonavida B
    Cancer Res; 1993 Jun; 53(11):2591-6. PubMed ID: 7684321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of Apo-1/Fas (CD95)-induced programmed cell death in myeloma cells by interferon-alpha 2.
    Egle A; Villunger A; Kos M; Böck G; Gruber J; Auer B; Greil R
    Eur J Immunol; 1996 Dec; 26(12):3119-26. PubMed ID: 8977313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced apoptosis following treatment with TRA-8 anti-human DR5 monoclonal antibody and overexpression of exogenous Bax in human glioma cells.
    Kaliberov S; Stackhouse MA; Kaliberova L; Zhou T; Buchsbaum DJ
    Gene Ther; 2004 Apr; 11(8):658-67. PubMed ID: 14973547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological effects of NO in malignant glioma cells: modulation by cytokines including CD95L and TGF-beta, dexamethasone, and p53 gene transfer.
    Rieger J; Ständer M; Löschmann PA; Heneka M; Dichgans J; Klockgether T; Weller M
    Oncogene; 1998 Nov; 17(18):2323-32. PubMed ID: 9811463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective activity of adult T cell leukemia-derived factor (ADF) against tumor necrosis factor-dependent cytotoxicity on U937 cells.
    Matsuda M; Masutani H; Nakamura H; Miyajima S; Yamauchi A; Yonehara S; Uchida A; Irimajiri K; Horiuchi A; Yodoi J
    J Immunol; 1991 Dec; 147(11):3837-41. PubMed ID: 1719091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-10 protects mouse intestinal epithelial cells from Fas-induced apoptosis via modulating Fas expression and altering caspase-8 and FLIP expression.
    Bharhani MS; Borojevic R; Basak S; Ho E; Zhou P; Croitoru K
    Am J Physiol Gastrointest Liver Physiol; 2006 Nov; 291(5):G820-9. PubMed ID: 17030898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis.
    Ungefroren H; Voss M; Jansen M; Roeder C; Henne-Bruns D; Kremer B; Kalthoff H
    Cancer Res; 1998 Apr; 58(8):1741-9. PubMed ID: 9563493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of vitamin K2 on osteoblast apoptosis: vitamin K2 inhibits apoptotic cell death of human osteoblasts induced by Fas, proteasome inhibitor, etoposide, and staurosporine.
    Urayama S; Kawakami A; Nakashima T; Tsuboi M; Yamasaki S; Hida A; Ichinose Y; Nakamura H; Ejima E; Aoyagi T; Nakamura T; Migita K; Kawabe Y; Eguchi K
    J Lab Clin Med; 2000 Sep; 136(3):181-93. PubMed ID: 10985496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-Fas on nonhematopoietic tumors: levels of Fas/APO-1 and bcl-2 are not predictive of biological responsiveness.
    Owen-Schaub LB; Radinsky R; Kruzel E; Berry K; Yonehara S
    Cancer Res; 1994 Mar; 54(6):1580-6. PubMed ID: 7511047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of bcl-2 on Fas antigen-mediated cell death.
    Itoh N; Tsujimoto Y; Nagata S
    J Immunol; 1993 Jul; 151(2):621-7. PubMed ID: 7687619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemosensitization of human prostate carcinoma cell lines to anti-fas-mediated cytotoxicity and apoptosis.
    Uslu R; Borsellino N; Frost P; Gárban H; Ng CP; Mizutani Y; Belldegrun A; Bonavida B
    Clin Cancer Res; 1997 Jun; 3(6):963-72. PubMed ID: 9815772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fas-mediated apoptosis in human prostatic carcinoma cell lines.
    Rokhlin OW; Bishop GA; Hostager BS; Waldschmidt TJ; Sidorenko SP; Pavloff N; Kiefer MC; Umansky SR; Glover RA; Cohen MB
    Cancer Res; 1997 May; 57(9):1758-68. PubMed ID: 9135020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fas (APO-1/CD95) signaling pathway is intact in radioresistant human glioma cells.
    Yount GL; Levine KS; Kuriyama H; Haas-Kogan DA; Israel MA
    Cancer Res; 1999 Mar; 59(6):1362-5. PubMed ID: 10096571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.